R J Bio-Tech Limited reported standalone unaudited earnings results for six months ended Sept. 30, 2016. For the period, the company reported total income from operations of INR 156.437 million, profit from operations before other income and finance costs and exceptional items of INR 162.456 million, loss from ordinary activities before tax of INR 6.02 million, net loss of INR 22.012 million or INR 1.32 basic and diluted per share compared to the total income from operations of INR 262.029 million, profit from operations before other income and finance costs and exceptional items of INR 198.688 million, profit from ordinary activities before tax of INR 63.341 million, net profit of INR 46.548 million or INR 4.92 basic and diluted per share for the same period a year ago.